Aksaray University Aksaray Training and Research Hospital
Aksaray, 68200, Turkey (Türkiye)
NCT Number: NCT05511155
Headache is one of the common causes of emergency department admissions and constitutes approximately 2%. Although the exact mechanism is not clear, It is known that high-flow oxygen therapy is effective in headache treatment. There are limited studies related to the use of oxygen therapy in headaches and its derivatives in the literature. In this study, the investigators aimed to compare the high and medium flow oxygen therapies with placebo in primary headache disorders.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Observational
Aksaray, 68200, Turkey (Türkiye)
Four different treatment methods were determined; 1) high-flow oxygen (15lt/min oxygen), 2) medium-flow oxygen (8lt/min oxygen), 3) high-flow room air as placebo (15 lt/min room air), 4) medium-flow room air as placebo (8 lt/min room air). All four treatment methods will be applied to all patients included in the study. One of the four treatments will be randomly applied at each separate ED admission with a gap of 1 week or more in between. This randomization will be performed by a computer at the time of admission. A study nurse will administer the patient's therapy according to the computer's current decision for 15 minutes. Patients and treating physicians will be blinded to the selected therapy. After 15 minutes of the end of treatment (at the 30th minute of the start of treatment), the treating physician will ask patients if they need rescue analgesia and analgesia will be administered if necessary. Additional analgesia is at the discretion of the treating physician. Patient data, including demographics, medical history, and findings of a physical examination performed before and after therapy will be recorded by the treating physician.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oxygen therapy will be given for 15 minutes with a non-rebreathing mask.
Time frame: 0-60 minutes
primary endpoint is the relative reduction in visual analog scale (a psychometric response scale) score in the placebo versus oxygen group to determine whether there was a difference between the high-flow and mid-flow therapies. visual analog scale scaled from 0-100 points with 0 meaning "no pain" and 100 points meaning "worst possible pain".
Time frame: 30 th minutes
rescue analgesia (yes/no)
Time frame: 0-300 minutes
length of stay in the emergency department (time in minutes)
Time frame: 0-300 minutes
duration of a pain attack (time in minutes)
Time frame: 0-7 days
readmission to the emergency department within 7 days (yes/no)
Aksaray University Training and Research Hospital
Other
Efficacy of Oxygen Therapy in Primary Headache Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00449787
Brain Diseases, Central Nervous System Diseases
New York, United States
View Trial DetailsNCT04178252
Brain Diseases, Central Nervous System Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05023460
Brain Diseases, Central Nervous System Diseases
Aarhus N, Denmark
View Trial DetailsNCT01073787
Brain Diseases, Central Nervous System Diseases
Edmonton, Alberta, Canada
View Trial Details